Unfortunately, no medicine that can cure NET patients with metastasized NET have been developed yet. The medication that is currently used can reduce tumor growth and/or combats the symptoms of NET.
Stopping medication before PRRT treatment
If possible, the patient should stop taking his/her octreotide long-acting 6 weeks before the therapy. The patient needs to switch to short-acting octreotide. This has to be stopped 24 hours before the treatment, also only if clinically safe and possible. In general the patient can restart with his/her short-acting octreotide again on the day he is discharged from the hospital.
Do not stop medication without consulting a physician.
Overview PRRT Steps
For a visual overview of the various steps before, during and after treatment, view the following schematic representations: